Rheumatoid vasculitis

Last updated
Rheumatoid vasculitis
Specialty Rheumatology   OOjs UI icon edit-ltr-progressive.svg

Rheumatoid vasculitis is a skin condition that is a typical feature of rheumatoid arthritis, presenting as peripheral vascular lesions that are localized purpura, cutaneous ulceration, and gangrene of the distal parts of the extremities. [1] [2]

Contents

Signs and symptoms

Rheumatoid vasculitis may affect almost any organ in the body. The skin and peripheral nerves are the most frequently affected areas. Although major organ system involvement of the kidney, bowel, or heart is much less common, it can result in serious morbidity and mortality, such as renal failure, bowel ischemia, and myocardial infarction. [3] While the involvement of the central nervous system is uncommon, numerous case reports document its occurrence. [4] [5]

Rheumatoid vasculitis can cause palpable purpura, ulcers, nodules, and digital necrosis on the skin. [6] Even though it is nonspecific and present in many different disorders, livedo reticularis is frequently observed. [3]

Peripheral nervous system involvement is the second most common organ involved. Peripheral nervous system manifestations include distal symmetric sensory polyneuropathy, distal motor or combined neuropathy, and mononeuritis multiplex. [3]

Causes

Patients who have nodular rheumatoid arthritis that is seropositive are nearly exclusively affected by rheumatoid vasculitis. [7]

Diagnosis

The patient's medical history and symptoms, physical examination, relevant laboratory tests, specialized testing (such nerve conduction studies), and tissue biopsy of the affected skin, muscle, nerves, or other organ are typically used to make the diagnosis.[ citation needed ]

Treatment

Treatment options for mild cases of rheumatoid vasculitis affecting the skin or peripheral nerves include methotrexate or azathioprine combined with prednisone. More severe organ system involvement might need to be treated with biologic agents, cyclophosphamide, and higher doses of steroids. [3]

See also

References

  1. ↑ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. Page 180. ISBN   0-7216-2921-0.
  2. ↑ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN   978-1-4160-2999-1.
  3. 1 2 3 4 Bartels, Christie M.; Bridges, Alan J. (September 15, 2010). "Rheumatoid Vasculitis: Vanishing Menace or Target for New Treatments?". Current Rheumatology Reports. 12 (6). Springer Science and Business Media LLC: 414–419. doi:10.1007/s11926-010-0130-1. ISSN   1523-3774. PMC   2950222 . PMID   20842467.
  4. ↑ Caballol Pons, Núria; Montalà, Núria; Valverde, José; Brell, Marta; Ferrer, Isidre; Martínez-Yélamos, Sergio (2010). "Isolated cerebral vasculitis associated with rheumatoid arthritis". Joint Bone Spine. 77 (4). Elsevier BV: 361–363. doi:10.1016/j.jbspin.2010.02.030. ISSN   1297-319X. PMID   20471884.
  5. ↑ Zolcinski, M.; Bazan-Socha, S.; Zwolinska, G.; Musial, J. (August 10, 2007). "Central nervous system involvement as a major manifestation of rheumatoid arthritis". Rheumatology International. 28 (3). Springer Science and Business Media LLC: 281–283. doi:10.1007/s00296-007-0428-0. ISSN   0172-8172. PMID   17690887. S2CID   32816100.
  6. ↑ Chen, K-R.; Toyohara, A.; Suzuki, A.; Miyakawa, S. (2002). "Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis". British Journal of Dermatology. 147 (5). Oxford University Press (OUP): 905–913. doi:10.1046/j.1365-2133.2002.04933.x. ISSN   0007-0963. PMID   12410699.
  7. ↑ Voskuyl, A E; Zwinderman, A H; Westedt, M L; Vandenbroucke, J P; Breedveld, F C; Hazes, J M (March 1, 1996). "Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study". Annals of the Rheumatic Diseases. 55 (3). BMJ: 190–192. doi:10.1136/ard.55.3.190. ISSN   0003-4967. PMC   1010127 . PMID   8712883.

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.